Session Information
Date: Sunday, November 8, 2015
Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose:
The interplay between effector and regulatory T cells (Tregs) is a key element among peripheral tolerance mechanisms in Systemic Lupus Erythematosus (SLE). Resistance to suppression has been acknowledged as part of the defects shown by lupus T cells. The E3 ligase Cbl-b has been shown to modulate T cell unresponsiveness in SLE. However its role in peripheral Tregs tolerance has not been addressed. The aim of this study was to assess Cbl-b expression and its relationship to the resistance to suppression phenotype, as well as the ubiquitination profile in SLE.
Methods:
We included 30 SLE patients (20 with active disease and 10 with clinical remission) and 30 age and gender matched healthy controls. Peripheral blood mononuclear cells were isolated by density-gradient sedimentation. Effector (CD4+CD25–) and Tregs (CD4+CD25+CD127–) were purified by magnetic selection. The expression of Cbl-b and the ubiquitination profile were analyzed by western blot. Proliferative responses were assessed in allogeneic and autologous cocultures by CFSE method. Differences were assessed by t Student test. p<0.05 was considered as statistically significant.
Results:
We found decreased Cbl-b expression in Tregs from SLE patients in comparison to healthy controls (1.1±0.9 vs 2.5±1.8+6, p=0.003), which was associated with resistance to suppression in proliferation assays (r=0.633, p=0.039). This phenomenon was related to a differential polyubiquitination profile characterized by deficient expression of Lys63 (K63) substrates in regulatory T cells from SLE patients when compared to healthy controls. We analyzed different signaling molecules that are prone to K63 regulation and found increased expression of phosphorylated STAT3 (pSTAT3) in T cells from SLE patients in comparison to healthy controls.
Conclusion: Our data suggest that Cbl-b is able to regulate the interplay between effector and Tregs, particularly, the resistance to suppression by regulating the K63 polyubiquitination profile in T cells from SLE patients. Moreover, deficient K63 polyubiquitination mainly of STAT3 is associated to the enhanced pSTAT3 expression and might play a role in the maintenance of resistance to suppression in SLE, as has been previously reported for other autoimmune diseases.
To cite this abstract in AMA style:
Gómez-Martín D, Alcocer-Varela J, Romo-Tena J, Barrera-Vargas A, Merayo-Chalico J. Lys63-Polyubiquitination By the E3 Ligase Casitas B-Lineage Lymphoma-b Modulates Peripheral Regulatory T Cell Tolerance in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/lys63-polyubiquitination-by-the-e3-ligase-casitas-b-lineage-lymphoma-b-modulates-peripheral-regulatory-t-cell-tolerance-in-patients-with-systemic-lupus-erythematosus/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/lys63-polyubiquitination-by-the-e3-ligase-casitas-b-lineage-lymphoma-b-modulates-peripheral-regulatory-t-cell-tolerance-in-patients-with-systemic-lupus-erythematosus/